{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:38:53Z","timestamp":1770975533695,"version":"3.50.1"},"reference-count":22,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1996,5]]},"abstract":"<jats:p>BACKGROUND--A study was conducted to evaluate the prevalence of metronidazole resistant Helicobacter pylori strains among the Chinese in Hong Kong. The efficacy of the triple therapy that contains metronidazole as one of the anti-microbial agents in eradication of the metronidazole susceptible and the metronidazole resistant strains was also assessed. METHODS--Culture for H pylori was attempted from antral biopsy specimens of 70 peptic ulcer and 51 control subjects. Successfully cultured H pylori strains were tested for metronidazole susceptibility. Twenty six peptic ulcer disease subjects who had received a course of triple therapy were also reassessed four to six weeks later for successful eradication of H pylori infection. RESULTS AND CONCLUSIONS--H pylori was successfully cultured from antral biopsy specimens in 69 of 80 (86%) of the infected subjects. The overall metronidazole resistance rate was 53.5% (37 of 69). There was a significantly higher metronidazole resistance rate among H pylori isolates from the asymptomatic controls (20 of 25) than the peptic ulcer disease subjects (17 of 44) (p = 0.0007). Twenty three of 32 (73%) women and 14 of 37 (38%) men harboured the metronidazole resistant strains. There was no sex or age difference as far as the prevalence of metronidazole resistant strains were concerned within each study group. Pre-treatment metronidazole susceptible H pylori were significantly more likely to respond to the triple therapy used than those with the metronidazole resistant ones (14 of 15 v five of 10) (p = 0.021).<\/jats:p>","DOI":"10.1136\/gut.38.5.675","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"675-678","source":"Crossref","is-referenced-by-count":50,"title":["Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong."],"prefix":"10.1136","volume":"38","author":[{"given":"C K","family":"Ching","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K P","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R W","family":"Yung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S K","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B C","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K C","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C L","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1996,5,1]]},"reference":[{"key":"ref_1","first-page":"116","volume":"89","author":"pylori, Marshall B.J.Helicobacter","year":"1994","unstructured":"Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89 (suppl): S 116-28.","journal-title":"Am J Gastroenterol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(94)91460-5","article-title":"Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial","volume":"343","author":"Hosking, S.W.; Ling, T.K.W.; Chung, S.C.S.; Yung, M.Y.; Cheng, A.F.; Sung, J.J.","year":"1994","unstructured":"Hosking SW, Ling TKW, Chung SCS, Yung MY, Cheng AF, Sung JJ, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3109\/00365529309098287","article-title":"Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori","volume":"28","author":"Thijs, J.C.; Zwet, A.A.; van Oey, H.B.","year":"1994","unstructured":"Thijs JC, Zwet AA, van Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand_J Gastroenterol 1994; 28: 934-8.","journal-title":"Scand_J Gastroenterol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-116-9-705","article-title":"Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized controlled study","volume":"116","author":"Graham, D.Y.; Lew, G.M.; Klein, P.D.; Evans, D.G.; DJ, Jr, Evans; Saeed, Z.A.","year":"1992","unstructured":"Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized controlled study. Ann Intern Med 1992; 116: 705-8.","journal-title":"Ann Intern Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/gut.35.1.19","article-title":"Evidence for the essential role of Helicobacter pylori in gastric ulcer disease","volume":"35","author":"Labenz, J.; Borsch, G.","year":"1994","unstructured":"Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994; 35: 19-22.","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM199501193320302","article-title":"Antibacterial treatment of gastric ulcers associated with Helicobacter pylori","volume":"332","author":"Sung, J.J.Y.; Chung, S.C.S.; Ling, T.K.W.; Yung, M.Y.; Leung, V.K.S.; Ng, E.K.W.","year":"1995","unstructured":"Sung JJY, Chung SCS, Ling TKW, Yung MY, Leung VKS, Ng EKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-42.","journal-title":"N Engl J Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","article-title":"Helicobacter pylori in peptic ulcer disease","volume":"272","author":"Consensus, N.I.H.","year":"1994","unstructured":"NIH Consensus. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/AAC.36.1.163","article-title":"Role of metronidazole resistance in therapy of Helicobacter pylori infections","volume":"36","year":"1992","unstructured":"Rautelin H, Seppala K, Renkonen 0, Vainio U, Kosunen TU. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163-6.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2036.1992.tb00556.x","article-title":"Experience with triple anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance","volume":"6","author":"Bell, G.D.; Powell, K.; Burridge, A.; Pallecaros, A.; Jones, P.H.; Gant, P.W.","year":"1992","unstructured":"Bell GD, Powell K, Burridge A, Pallecaros A, Jones PH, Gant PW, et al. Experience with triple anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6: 427-35.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0140-6736(91)92111-E","article-title":"One week eradication regimen for Helicobacter pylori","volume":"338","author":"Logan, R.P.H.; Gummett, P.A.; Misiewicz, J.; Karim, Q.N.; Walker, M.M.; Baron, J.H.","year":"1991","unstructured":"Logan RPH, Gummett PA, Misiewicz J, Karim QN, Walker MM, Baron JH. One week eradication regimen for Helicobacter pylori. Lancet 1991; 338: 1249-52.","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0016-5085(92)90095-G","article-title":"Factors influencing the eradication of Helicobacter pylori with triple therapy","volume":"102","author":"Graham, D.Y.; Lew, G.M.; Malaty, H.M.; Evans, D.G.; DJ, Jr, Evans; Klein, P.D.; et at","year":"1992","unstructured":"Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, et at. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.","journal-title":"Gastroenterology"},{"key":"ref_12","first-page":"934","article-title":"Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori","volume":"28","author":"Thijs, J.C.; Zwet, A.A.; van Oey, H.B.","year":"1993","unstructured":"Thijs JC, Zwet AA, van Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. ScandJ3 Gastroenterol 1993; 28: 934-8."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF01960875","article-title":"Results of a multicentre European Survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur3'","volume":"11","author":"Glupczynski, Y.; Burette, A.; Goossens, H.; DePrez, C.; Butzler, J.P.","year":"1992","unstructured":"Glupczynski Y, Burette A, Goossens H, DePrez C, Butzler JP. Results of a multicentre European Survey in 1991 of metronidazole resistance in Helicobacter pylori. Eur3' Ctin Microbiol Infect Dis 1992; 11: 777-81.","journal-title":"Ctin Microbiol Infect Dis"},{"key":"ref_14","first-page":"976","volume-title":"Metronidazole resistance in Helicobacter pylori. Lancet","volume":"335","author":"Glupcznski, Y.; Burrette, A.; DeKoster, E.; Nust, J.F.; Deltenre, M.; Cadranel, S.","year":"1990","unstructured":"Glupcznski Y, Burrette A, DeKoster E, Nust JF, Deltenre M, Cadranel S, et al. Metronidazole resistance in Helicobacter pylori. Lancet 1990; 335: 976-7."},{"key":"ref_15","first-page":"1203","article-title":"and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection","volume":"89","author":"Al-Assi, M.T.; Ramirez, F.C.; Lew, G.M.; Genta, R.M.; Clarithromycin, Graham D.Y.; tetracycline","year":"1994","unstructured":"Al-Assi MT, Ramirez FC, Lew GM, Genta RM, Graham DY. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. AmJ Gastroenterol 1994; 89: 1203-5.","journal-title":"AmJ Gastroenterol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1440-1746.1987.tb00168.x","article-title":"Pathogenetic role of Campylobacter in gastric ulcer","volume":"2","author":"Hui, W.M.; Lam, S.K.; Chau, P.Y.; Ho, J.; Lau, W.Y.; Poon, K.P.","year":"1987","unstructured":"Hui WM, Lam SK, Chau PY, Ho J, Lau WY, Poon KP, et al. Pathogenetic role of Campylobacter in gastric ulcer. Jf Gastroenterol Hepatol 1987; 2: 309-16.","journal-title":"Jf Gastroenterol Hepatol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1128\/JCM.31.8.1971-1974.1993","article-title":"Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance","volume":"31","author":"DeCross, A.J.; Marshall, B.J.; McCallum, R.W.; Hoffman, SR, Barrett; U, Guerrant; R.L.","year":"1993","unstructured":"DeCross AJ, Marshall BJ, McCallum RW, Hoffman SR, Barrett U, Guerrant RL. Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. _J Clin Microbiol 1993; 31: 1971-4.","journal-title":"_J Clin Microbiol"},{"key":"ref_18","article-title":"Ching CK. Sucralfate in Helicobacter pylori eradication strategies","author":"Lam, S.K.; Hu, W.H.C.","unstructured":"Lam SK, Hu WHC, Ching CK. Sucralfate in Helicobacter pylori eradication strategies. Scand J Gastroenterol (in press).","journal-title":"Scand J Gastroenterol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2036.1993.tb00083.x","article-title":"Two-week eradication regimen for metronidazole-resistant Helicobacter pylori","volume":"7","author":"Logan, R.P.H.; Gummett, P.A.; Misiewicz, J.J.; Karim, Q.N.; Walker, M.M.; Baron, J.H.","year":"1993","unstructured":"Logan RPH, Gummett PA, Misiewicz JJ, Karim QN, Walker MM, Baron JH. Two-week eradication regimen for metronidazole-resistant Helicobacter pylori. Aliment Pharnacol Ther 1993; 7: 149-53.","journal-title":"Aliment Pharnacol Ther"},{"key":"ref_20","first-page":"48","article-title":"Short-term double or triple oral drug treatment of Helicobacter pylori","volume-title":"(Hp) in Central Africa. Gastroenterology 1990","volume":"98","author":"Glupczynski, Y.; Buordeaux, L.; Verhas, M.","unstructured":"Glupczynski Y, Buordeaux L, Verhas M. Short-term double or triple oral drug treatment of Helicobacter pylori (Hp) in Central Africa. Gastroenterology 1990; 98: A48."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2036.1992.tb00740.x","article-title":"Short report: Omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori","volume":"6","author":"Bell, G.D.; Powell, K.U.; Burridge, S.M.; Spencer, G.; Bolton, G.; Purser, K.","year":"1992","unstructured":"Bell GD, Powell KU, Burridge SM, Spencer G, Bolton G, Purser K, et al. Short report: Omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther 1992; 6: 751-8.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2036.1994.tb00170.x","article-title":"Clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection","volume":"8","author":"Thijs, J.C.; Zwet, A.A.; van Moolenaar, W.; Oom, J.A.J.; DeKores, H.; Runhaar, A.","year":"1994","unstructured":"Thijs JC, Zwet AA, van Moolenaar W, Oom JAJ, DeKores H, Runhaar A. Clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection. Aliment Pharmacol Ther 1994; 8: 131-4.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.38.5.675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T21:05:24Z","timestamp":1765659924000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.38.5.675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[1996,5,1]]},"published-print":{"date-parts":[[1996,5]]}},"alternative-id":["10.1136\/gut.38.5.675"],"URL":"https:\/\/doi.org\/10.1136\/gut.38.5.675","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}